Question 1

What is Enlivex Therapeutics?

Accepted Answer

Enlivex Therapeutics is a Company.

Question 2

How often does Enlivex Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Enlivex Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 28, 2026.

Question 4

When was Enlivex Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 07, 2026.

Question 5

What is Enlivex Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Enlivex Therapeutics in global news coverage?

Accepted Answer

Attention score of 1, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Enlivex Therapeutics?

Accepted Answer

Enlivex 1-for-15 Reverse Stock Split (Jul 07, 2026, 7 articles).

Question 8

How did the "Enlivex 1-for-15 Reverse Stock Split" event impact Enlivex Therapeutics?

Accepted Answer

Enlivex Therapeutics is implementing a 1-for-15 reverse stock split to increase its share price and maintain Nasdaq listing. The stock declined in pre-market trading, indicating negative investor sentiment.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.